Silicosis-Associated Tuberculosis: Management and Control

Attapon Cheepsattayakorn^{1, 2,} and Ruangrong Cheepsattayakorn^{3, 4}

¹Chief Guest Editor, Special Issue ¡°Tuberculosis and Respiratory Diseases Among Silica and Other Dust Exposed Workers¡±, American Journal of Public Health Research

²10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand;Department of Disease Control, Ministry of Public Health, Thailand

³Guest Editor, Special Issue ¡°Tuberculosis and Respiratory Diseases Among Silica and Other Dust Exposed Workers¡±, American Journal of Public Health Research

⁴Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Cite this paper:
Attapon Cheepsattayakorn and Ruangrong Cheepsattayakorn. Silicosis-Associated Tuberculosis: Management and Control. American Journal of Public Health Research. 2018; 6(2):125-129. doi: 10.12691/ajphr-6-2-17

Abstract

Silica-associated diseases, including tuberculosis and other related diseases, such as COPD, lung cancer, autoimmune diseases, renal diseases, etc. remain an important public health concern in the 21th century. Silica exposures and silicosis increase the risk of active tuberculosis development by approximately 30-40 times, compared to populations without silica exposure. Workers with periods of silica exposure longer than 10 years should be provided tuberculosis chemoprophylaxis. Although evidences of silicosis are not detected, the risk of active tuberculosis can increase. However, further studies are urgently needed to identify the best chemoprophylaxis regimen for tuberculosis.

Keywords:
silicosis silicosis-associated tuberculosis silica tuberculosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	World Health Organization. Crystalline Silica, Quartz. (Concise International Chemical Assessment Document (CICAD) no. 24). Geneva, Switzerland: World Health Organization; 2000.
[2]	Zhang M., Zheng Y.D., Du X.Y., et al., Silicosis in automobile foundry workers: a 29-year cohort study. Biomed Environ Sci, 23: 121-9, Apr 2010.
[3]	National Institute for Occupational Safety and Health. NIOSH Hazard Review. Health Effects of Occupational Exposure to Respirable Crystalline Silica. Morgantown, WV: National Institute for Occupational Safety and Health; 2002. (DHHS (NIOSH) publication no. 2002-1290. (http://www.cdc.gov/niosh/docs/2002-129/02-129a.html). (Accessed on 28 February 2018).
[4]	Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep, 49: 1-51, Jun 2000.
[5]	Steenland K., One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure. Am J Ind Med, 48: 16-23, Jul 2005.
[6]	Yassin A., Yebesi F., Tingle R., Occupational exposure to crystalline silica dust in the United States, 1988-2003. Environ Health Perspect, 113: 255-60, Mar 2005.
[7]	Fedotov I., Global elimination of silicosis: the ILO/WHO international program. Asian-Pacific Newsletter on Occupational Health and Safety, 4: 4-7, Jan-Feb 1997.
[8]	Cowie R.L., Murray J., Becklake M.R. Pneumoconioses. In: Mason R.J., Broaddus V.C., Murray J.F., Nadel J.A., eds. Murray and Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia, PA, USA: Elsevier Saunders, 2005: pp 1748-82.
[9]	Aungkasuvapala N., Juengprasert W., Obhasi N., Silicosis and pulmonary tuberculosis in stone-grinding factories in Saraburi, Thailand. J Med Assoc Thai, 78: 662-9, Dec 1995.
[10]	Parkes W.R., Occupational Lung Disorders. 3rd ed. London, UK: Butterworth, 1994.
[11]	Hubbs A., Greskevitch M., Kuempel E., et al., Abrasive blasting agents: designing studies to evaluate relative risk. J Toxicol Environ Health A, 68: 999-1016, Jun 2005.
[12]	American Thoracic Society. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med, 155: 761-8, Feb 1997.
[13]	Gibbs A.R., Wagner J.C. Diseases due to silica. In: Churg A., Green F.H.Y., eds. Pathology of Occupational Lung Disease. 2nd ed. Baltimore, MD, USA: Williams & Wilkins, 1998: pp 209-33.
[14]	Donaldson K., Mechanism of pneumoconiosis. In: Banks D.E., Parker J.E. eds. Occupational Lung Diseases: An International Perspective. London, UK: Chapman and Hall Medical, 1998: pp 139-60.
[15]	Terra-Filho M., Santos U.P., Silicosis. J Bras Pneumol, 32: (Suppl 2): S41-7, Nov-Dec 2006.
[16]	Davis G.S. Silicosis. In: Hendick D.J., Burge P.S., Beckett W.S., Churg A., editors. Occupational disorders of the lung: recognition, management and prevention. London: W.B. Saunders, 2002: pp. 105-27.
[17]	Organizacao Internacional do Trabalho. Diretrizes para Utilizacao da Classificacao Internacional da OIT de Radiografias de Pneumoconioses. Sao Paulo: OIT; 2005.
[18]	International Labour Office. Guidelines for the use the ILO International Classification of Radfiographs. Rev ed. Geneva, Switzerland: ILO, 2000.
[19]	Talini D., Paggiaro P.L., Falaschi F., et al., Chest radiography and high resolution computed tomography in the evaluation of workers exposed to silica dust: relation with functional findings. Occup Environ Med, 52: 262-7, Apr 1995.
[20]	Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol, 30 (Suppl 1): S1-86, Jun 2004.
[21]	Snider D.E. Jr., The relationship between tuberculosis and silicosis. Am Rev Respir Dis, 119: 515, Mar 1979.
[22]	Bombarda S., Figueiredo C.M., Funari M.B., et al., Imagem em tuberculose pulmonar. J Pneumol, 27: 329-40, Nov-Dec 2001.
[23]	Charoenratanakul S., Dejsomritrutai W., Chaiprasert A., Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis. Respir Med, 89: 621-3, Oct 1995.
[24]	Lee K.S., Hwang J.W., Chung M.P., et al., Utility of CT in the evaluation of pulmonary tuberculosis in patients without AIDS. Chest, 110: 977-84, Oct 1996.
[25]	Chong S., Lee K.S., Chung M.J., et al., Pneumoconioses: comparison of imaging and pathologic findings. Radiographics, 26: 59-77, Jan-Feb 2006.
[26]	Barboza C.E.G., Winter D.H., SeiscentoIII, et al., Tuberculosis and silicosis: ep[idemiology, diagnosis and chemoprophylaxis. J Bras Pneumol, 34: 10 pages, Nov 2008.
[27]	Cowie R.L., The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med, 150: 1460-2, Nov 1994.
[28]	A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis, 145: 36-41, Jan 1992.
[29]	Grant A.D., Charalambous S., Fielding K.L., et al., Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA, 293: 2719-25, Jun 2005.
[30]	Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med, 161 (Suppl): S221-S247, Apr 2000.
[31]	Hnizdo E., Vallyathan V., Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup Environ Med, 60: 237-43, Apr 2003.
[32]	Hessel P.A., Progression of silicosis in relation to silica dust exposure. Ann Occup Hyg, 32: 689-96, Jan 1988.
[33]	Buchanan D., Miller B.G., Soutar C.A., Quantitative relations between exposure to respirable quartz and risk of silicosis. Occup Environ Med, 60: 159-64, Mar 2003.
[34]	Greaves I.A., Not-so-simple silicosis: a case for public health action. Am J Ind Med, 37: 245-51, Mar 2000.
[35]	American Conference of Governmental Industrial Hygienists. 2006 TLVs and BEIs. Cincinnati, OH, USA: ACGIH, 2006.
[36]	Calvert G.M., Rice F.L., Boiano J.M., et al., Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med, 60: 122-9, Feb 2003.
[37]	Chopra K., Prakash P., Bhansali S., et al., Incidence and prevalence of silicotuberculosis in western Rajasthan: a retrospective study of three years. Nat J Com Med, 3: 161-3, Jan-Mar 2012.
[38]	Rosenman K.D., Hall N., Occupational risk factors for developing tuberculosis. Am J Ind Med, 30: 148-54, Aug 1996.
[39]	Ferreira A.S., Moreira V.B., Ricardo H.M., et al., Progressive massive fibrosis in silica-exposed workers: high-resolution computed tomography findings. J Bras Pneumol, 32: 523-8, Nov-Dec 2006.
[40]	Miners' Phthisis Prevention Committee. The prevention of silicosis in the miners of Witwatersrand. Report GP-S 8072. Pretoria, South Africa: Union of South Africa, 1937.
[41]	Costello J., Graham W.G., Vermont granite workers' mortality study. Am J Ind Med, 13: 483-97, Apr8 1988.
[42]	Lahiri S., Levenstein C., Nelson D.I., et al., The cost-effectiveness of occupational health interventions: prevention of silicosis. Am J Ind Med, 48: 503-14, Dec 2005.
[43]	Hnizdo E., Murray J., Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med, 55: 496-502, Jul 1998 and Erratum in: Occup Environ Med, 56: 215-6, Mar 1999.
[44]	teWaternaude J.M., Ehrlich R.I., Churchyard G.J., et al., Tuberculosis and silica exposure in South African gold miners. Occup Environ Med, 63: 187-92, Mar 2006.
[45]	Steen T.W., Gyi K.M.,White N.W., et al., Prevalence of occupational lung disease among Botswana men formerly employed in the South African mining industry. Occup Environ Med, 54: 19-26, Jan 1997.
[46]	Trapido A.S., Mqoqi N.P., Williams B.G., et al., Prevalence of occupational lung disease in a random sample of former mine-workers, Libode District, Eastern Cape Province, South Africa. Am J Ind Med, 34: 305-13, Oct 1998.